Related Experiment Video
Updated: May 26, 2026

An Affordable HIV-1 Drug Resistance Monitoring Method for Resource Limited Settings
Published on: March 30, 2014
High HIV incidence among MSM prescribed postexposure prophylaxis, 2000-2009: indications for ongoing sexual risk
José Heuker1, Gerard J B Sonder, Ineke Stolte
1Department of Infectious Diseases, Public Health Service, Amsterdam, The Netherlands.
Objective:
To determine (trends in) HIV incidence among MSM\ who have recently had postexposure prophylaxis (PEP) prescribed in Amsterdam, compared with MSM participating in the Amsterdam Cohort Studies (ACS).
Design And Methods:
We used data from MSM who were prescribed PEP in Amsterdam between 2000 and 2009, who were HIV-negative at the time of PEP prescription and had follow-up HIV testing 3 and/or 6 months after PEP prescription (n = 395). For comparison, cohort data from MSM participating in the ACS in the same period were used (n = 782). Poisson log-linear regression analyses were performed to model trends in HIV incidence and identify differences in HIV incidence between both cohorts at different time points.
Results:
Between 2000 and 2009, among MSM who were prescribed PEP, an overall HIV incidence of 6.4 [95% confidence interval (CI) 3.4-11.2] per 100 person-years was found, compared with an HIV incidence of 1.6 (95% CI 1.3-2.1) per 100 person-years among MSM participating in the ACS (P < 0.01). In both cohorts, an increasing trend in HIV incidence over time was observed [incidence rate ratio (IRR(per calendar year)) 1.3 (95% CI 0.9-1.7) and 1.1 (95% CI 1.0-1.2) among MSM prescribed PEP and MSM of the ACS, respectively]. The difference in HIV incidence between both cohorts was most evident in more recent years [IRR(PEP versus ACS in 2009) 4.8 (95% CI 2.0-11.5)].
Conclusion:
Particularly in more recent years, MSM recently prescribed PEP had a higher HIV incidence compared with MSM participating in the ACS, indicating ongoing sexual risk behaviour.
Insights
Men who have sex with men (MSM) recently prescribed postexposure prophylaxis (PEP) showed higher HIV incidence compared to those in the Amsterdam Cohort Studies (ACS). This highlights ongoing sexual risk behaviors in this population.
Area of Science:
- Public Health
- Epidemiology
- HIV/AIDS Research
Background:
- HIV prevention strategies are crucial for men who have sex with men (MSM).
- Postexposure prophylaxis (PEP) is a key intervention for HIV prevention.
- Understanding HIV incidence trends in specific populations is vital for targeted public health efforts.
Purpose of the Study:
- To compare HIV incidence trends among MSM prescribed PEP with those in the Amsterdam Cohort Studies (ACS).
- To identify temporal changes in HIV incidence within these two groups of MSM.
- To assess the effectiveness of PEP in the context of ongoing sexual risk behaviors.
Main Methods:
- Retrospective analysis of HIV-negative MSM prescribed PEP in Amsterdam (2000-2009).
- Comparison with HIV incidence data from MSM in the Amsterdam Cohort Studies (ACS) during the same period.
- Poisson log-linear regression to model HIV incidence trends and differences between cohorts.
Main Results:
- HIV incidence was significantly higher in MSM prescribed PEP (6.4 per 100 person-years) compared to ACS participants (1.6 per 100 person-years).
- Both groups showed an increasing trend in HIV incidence over time.
- The disparity in HIV incidence between the PEP and ACS groups widened in more recent years.
Conclusions:
- MSM recently prescribed PEP exhibited a higher HIV incidence, particularly in recent years, compared to the general MSM cohort.
- This finding suggests persistent sexual risk behaviors among MSM utilizing PEP.
- Public health strategies may need to address ongoing risk behaviors in conjunction with PEP provision.
Related Concept Videos
Sexually Transmitted Infections
Retrovirus Life Cycles
Transmission-based Precautions I: Contact, Enteric, and Droplets
Contact Precautions:
Contact precautions are the measures taken to prevent the transmission of infectious agents, especially epidemiologically important microorganisms such as MRSA or influenza, primarily transmitted through direct or indirect contact with an...
Healthcare Associated Infections II: Preventive Measures
The best practices for preventing healthcare-associated infections include hand hygiene, patient risk...
Pulmonary Tuberculosis I
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Factors Affecting the Risk of Infection
The integrity and count of the white blood cells help the body resist pathogens and fight infection. When impaired, it reduces the body's resistance to pathogens. The acidic pH levels of the gastrointestinal, genitourinary tracts, and skin create...

